Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials.
暂无分享,去创建一个
H. Liao | N. Frahm | M. McElrath | D. Friedrich | D. Carter | Rebecca J Smith | P. Walsh | Julie A. Williams | T. Stewart
[1] Guido Ferrari,et al. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. , 2013, Immunity.
[2] Tomer Hertz,et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 , 2012, Nature.
[3] Jessica B. Graham. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial , 2012 .
[4] W. Blattner,et al. A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) , 2011, PloS one.
[5] Bernard Klein,et al. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138− and CD138+ plasma cells , 2010, Haematologica.
[6] S. Plotkin. Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.
[7] J. Hoxie,et al. Selective Expansion of HIV-1 Envelope Glycoprotein-Specific B Cell Subsets Recognizing Distinct Structural Elements Following Immunization1 , 2009, The Journal of Immunology.
[8] B. Haynes,et al. HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection1 , 2009, The Journal of Immunology.
[9] T. Lebien,et al. B lymphocytes: how they develop and function. , 2008, Blood.
[10] Nichole E Carlson,et al. Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.
[11] L. Baddour. Duration of Humoral Immunity , 2007 .
[12] Kenneth G. C. Smith,et al. Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.
[13] T. Giese,et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. , 2004, Blood.
[14] R. Ahmed,et al. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.
[15] Luis Villarreal,et al. Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.
[16] R. Coffman,et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions , 2003, Journal of leukocyte biology.
[17] Andreas Radbruch,et al. Humoral immunity and long-lived plasma cells. , 2002, Current opinion in immunology.
[18] G. Bishop,et al. Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-8481 , 2000, The Journal of Immunology.
[19] T. Waldschmidt,et al. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. , 2000, Cellular immunology.
[20] S Miltenyi,et al. Correlation analysis between frequencies of circulating antigen‐specific IgG‐bearing memory B cells and serum titers of antigen‐specific IgG , 1999, European journal of immunology.
[21] G. Calandra,et al. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. , 1996, Vaccine.
[22] B. Kay,et al. High-throughput biotinylation of proteins. , 2009, Methods in molecular biology.
[23] L. McHeyzer-Williams,et al. Antigen-specific memory B cell development. , 2005, Annual review of immunology.
[24] A. Billich. AIDSVAX VaxGen. , 2004, Current opinion in investigational drugs.